Work

N0937(Alliance): Final clinical results and correlative data from the phase II trial of cisplatin (C) and the novel agent brostallicin (B) in patients with metastatic triple-negative breast cancer (mTNBC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.1059

Authors: Alvaro Moreno-Aspitia, Heshan Liu, David W. Hillman, Kendrith M. Rowland, Xochiquetzal Geiger, Philip J. Stella, Peter Kourlas, Howard M. Gross, Nina J. Karlin, Martin J. Bury, Gamini S. Soori, Aziza Nassar, Edith A. Perez

Institutions: Mayo Clinic in Florida, Mayo Clinic, Trinity Health Michigan, Mayo Clinic in Arizona, Missouri Valley Cancer Consortium

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2243378678

Cites:

Cited by:

Related to: 10